Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatolog…

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Protagonist Therapeutics: Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults furt ...
Bleeding Cool

Phantasy Star Online 2 New Genesis Reveals April Content Plans

SEGA held a new livestream this week for Phantasy Star Online 2 New Genesis, showing off all the events and content for April ...
Tech Times

How to Choose and Build the Best Class in 'Diablo IV: Lord of Hatred' in Season 10

Learn how to choose and build the best class in Season 10 of "Diablo IV: Lord of Hatred," including the new Warlock class.

UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis

UCB, a global biopharmaceutical company, today announced new data in moderate-to-severe plaque psoriasis (PSO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, March 27–31.
Pro Game Guides

Star Savior Tier List & Reroll Guide (March 2026)

Star Savior is an anime-style turn-based idle RPG featuring a wide roster of characters known as Saviors. There are 42 characters, each with their own ...